ChinaNanomedicine refers to conference series on nanomedicine imitated and sponsored by the National Center for Nanoscience and Technology and the Nanomedicine Committee of Chinese Pharmaceutical Association. So far, the conference has been successfully held for three times respectively in Shanghai (2018), Hangzhou of Zhejiang Province (2015) and Wuhan of Hubei Province (2016), become one of the most important academic events in the field of nanomedicine research and clinical transformation in China and abroad, and received extensive attention and high reputation from domestic and foreign counterparts.
ChinaNanomedicine 2018 was hosted by Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Nanomedicine Committee of Chinese Pharmaceutical Association, Nano-oncology Committee of China Anti-Cancer Association, Nanotoxicology Committee of Chinese Society of Toxicology, Nanochemistry Committee of Chinese Chemical Society, and National Pharmaceutical Engineering Research Center. Academician Yuliang Zhao, who was the Director of National Center for Nanoscience and Technology and Chairman of Nanomedicine Committee of Chinese Pharmaceutical Association, acted as the General Chair and Prof. Yaping Li from Shanghai Institute of Materia Medica, Chinese Academy of Sciences served as the Executive General Chair. More than 1,300 experts, scholars and postgraduate representatives from abroad and mainland China participated in the conference. The conference report covered more than 10 fields including nanomedicine, nanotechnology for targeted drug delivery, nanomedicine for tumor microenvironment, nanomedicine for tumor immunotherapy, industrial nano-pharmaceutical, nanoparticle probes for molecular imaging, nanomedicine for in vitro diagnosis, mobile medical nanotechnology, nanotechnology for bio-separation and bio-analysis, nano-biomedical materials and tissue engineering, nano–bio interface, nanotoxicology and biological safety, etc. Participants conducted multidisciplinary discussions and in-depth exchange around the conference theme. It is expected to promote broad cooperation in nanomedicine research field at home and abroad.
ChinaNanomedicine refers to conference series on nanomedicine imitated and sponsored by the National Center for Nanoscience and Technology and the Nanomedicine Committee of Chinese Pharmaceutical Association. So far, the conference has been successfully held for three times respectively in Shanghai (2018), Hangzhou of Zhejiang Province (2015) and Wuhan of Hubei Province (2016), become one of the most important academic events in the field of nanomedicine research and clinical transformation in China and abroad, and received extensive attention and high reputation from domestic and foreign counterparts.
ChinaNanomedicine 2018 was hosted by Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Nanomedicine Committee of Chinese Pharmaceutical Association, Nano-oncology Committee of China Anti-Cancer Association, Nanotoxicology Committee of Chinese Society of Toxicology, Nanochemistry Committee of Chinese Chemical Society, and National Pharmaceutical Engineering Research Center. Academician Yuliang Zhao, who was the Director of National Center for Nanoscience and Technology and Chairman of Nanomedicine Committee of Chinese Pharmaceutical Association, acted as the General Chair and Prof. Yaping Li from Shanghai Institute of Materia Medica, Chinese Academy of Sciences served as the Executive General Chair. More than 1,300 experts, scholars and postgraduate representatives from abroad and mainland China participated in the conference. The conference report covered more than 10 fields including nanomedicine, nanotechnology for targeted drug delivery, nanomedicine for tumor microenvironment, nanomedicine for tumor immunotherapy, industrial nano-pharmaceutical, nanoparticle probes for molecular imaging, nanomedicine for in vitro diagnosis, mobile medical nanotechnology, nanotechnology for bio-separation and bio-analysis, nano-biomedical materials and tissue engineering, nano–bio interface, nanotoxicology and biological safety, etc. Participants conducted multidisciplinary discussions and in-depth exchange around the conference theme. It is expected to promote broad cooperation in nanomedicine research field at home and abroad.
Close Page- Text Size: A A A
Printer Friendly
